William Blair analyst Andy Hsieh initiated coverage of BioAge Labs (BIOA) with a Market Perform rating.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOA:
- Hold Rating for BioAge Labs, Inc.: Balancing Innovative Potential with Competitive and Developmental Challenges
- BIOA Lawsuit Alert! Class Action Lawsuit Against BioAge Labs, Inc.
- Nine new option listings on February 12th
- BioAge Labs provides updates, terminates development of azelaprag
- Levi & Korsinsky LLP Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline